Results (
Indonesian) 1:
[Copy]Copied!
Management of recurrent CDI (RCDI)19. The first recurrence of CDI can be treated with the same regimen that was used for the initial episode. If severe, however vancomycin should be used. The second recurrence should be treated with a pulsed vancomycin regimen. (Conditional recommendation, low-quality evidence)20. If there is a third recurrence after a pulsed vancomycin regimen, fecal microbiota transplant (FMT) should be considered. (Conditional recommendation,moderate-quality evidence)21. There is limited evidence for the use of adjunct probiotics to decrease recurrences in patients with RCDI. (Moderate recommendation, moderate-quality evidence)22. No effective immunotherapy is currently available. Intravenous immune globulin (IVIG) does not have a role as sole therapy in treatment of RCDI. However, it may be helpful in patients with hypogammaglobulinemia. (Strong recommendation, low-quality evidence) Management of patients with CDI and co-morbid conditions23. All patients with IBD hospitalized with a disease flare should undergo testing for CDI. (Strong recommendation, high-quality evidence)24. Ambulatory patients with IBD who develop diarrhea in the setting of previously quiescent disease, or in the presence of risk factors such as recent hospitalization, or antibiotic use, should be tested for CDI. (Strong recommendation, moderate-quality evidence)25. In patients who have IBD with severe colitis, simultaneous initiation of empiric therapy directed against CDI and treatment of an IBD fl are may be required while awaiting results of C. diffi cile testing. (Conditional recommendation, low-quality evidence)
Being translated, please wait..